BioMarker Strategies Revenue and Competitors
Estimated Revenue & Valuation
- BioMarker Strategies's estimated annual revenue is currently $465k per year.
- BioMarker Strategies's estimated revenue per employee is $77,500
- BioMarker Strategies's total funding is $5.7M.
Employee Data
- BioMarker Strategies has 6 Employees.
- BioMarker Strategies grew their employee count by -40% last year.
BioMarker Strategies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Business Office Manager | Reveal Email/Phone |
2 | President/CEO | Reveal Email/Phone |
3 | Sr. consultant Health Technology | Reveal Email/Phone |
4 | Office Administrator | Reveal Email/Phone |
BioMarker Strategies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is BioMarker Strategies?
BioMarker Strategies is a Baltimore, MD-based cancer diagnostics company developing the novel SnapPath™ live-tumor-cell biomarker testing system to improve the treatment of cancer. This automated, patent-pending system is designed to help pathologists and oncologists predict patient response to chemotherapies and targeted cancer therapeutics, reduce unnecessary surgical biopsies and obtain information on treatment options that is not available using current tumor-cell processing methods.
keywords:N/A
$5.7M
Total Funding
6
Number of Employees
$465k
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioMarker Strategies News
Innovative biosensor-based strategies could allow biomarkers to be tested reliably in a decentralised setting. Early diagnosis of COVID-19...
... in DCIS Suggest Undertreatment With Biomarker-Directed Strategies ... using these genetic biomarkers for prediction of recurrence is a...
The poster presentations describe the study design and a highly innovative biomarker strategy employed in the study and are being delivered at...
Other Companies in Redland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | N/A | N/A |
#2 | $0.3M | 8 | 0% | $33.6M |
#3 | $10.3M | 40 | 11% | N/A |
#4 | $16.1M | 104 | 5% | N/A |
#5 | $34.5M | 174 | 5% | N/A |